CURI vs PRCH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CURI Captures Institutional Edge (2โ2 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CuriosityStream Inc. Class A Common Stock (CURI) driven by superior Valuation, Growth & Margin while PRCH counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CURI trades at 8.7x Forward P/E with 10.1% operating margin (+12.9% YoY revenue) versus PRCH at 62.6x Forward P/E and 8.0% operating margin (+13.0% YoY). In options structure, CURI sits in CONSOLIDATION (55th %ile IV; Dealer Gamma Walls on Pro) against PRCH sits in BREAKOUT (13th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CURI Revenue | PRCH Revenue | CURI Op. Margin | PRCH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $20M | $80M | -247.4% | -113.6% | PRCH |
| FY2020 | $40M | $70M | -97.9% | -58.4% | PRCH |
| FY2021 | $70M | $190M | -73.6% | -43.3% | PRCH |
| FY2022 | $80M | $280M | -70.8% | -64.2% | PRCH |
| FY2023 | $60M | $290M | -78.2% | -66.2% | PRCH |
| FY2024 | $50M | $310M | -26.1% | -20.6% | PRCH |
| FY2025 | $70M | $420M | -10.2% | 8.7% | PRCH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CURI | PRCH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $185.7M | $2.4B | Larger Scale | PRCH |
| Trailing P/E Ratio Valuation | 20.9x | N/M | Lower Multiple | CURI |
| Forward P/E Ratio Valuation | 8.7x | 62.6x | Lower Multiple | CURI |
| Revenue Growth (YoY) Growth | +12.9% | +13.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 10.1% | 8.0% | Higher Margin | CURI |
| Net Profit Margin Profitability | 11.0% | 1.8% | Higher Margin | CURI |
| Return on Equity (ROE) Capital Efficiency | 19.3% | 5.6% | Higher ROE | CURI |
| 52-Week Range Position Momentum | 32% ($2โ$5) | 91% ($6โ$22) | Stronger Trend | PRCH |
| Beta / 30D Volatility Risk Regime | 1.29ฮฒ ยท 94% Vol | 1.59ฮฒ ยท 114% Vol | Lower Realized Risk | CURI |
| Unified Institutional Score Composite Signal | 36.5 / 100 (SELL) | 47.3 / 100 (HOLD) | Higher Composite | PRCH |